1. Home
  2. EDSA vs WKSP Comparison

EDSA vs WKSP Comparison

Compare EDSA & WKSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EDSA
  • WKSP
  • Stock Information
  • Founded
  • EDSA 2015
  • WKSP 2003
  • Country
  • EDSA Canada
  • WKSP United States
  • Employees
  • EDSA N/A
  • WKSP N/A
  • Industry
  • EDSA Biotechnology: Pharmaceutical Preparations
  • WKSP Auto Parts:O.E.M.
  • Sector
  • EDSA Health Care
  • WKSP Consumer Discretionary
  • Exchange
  • EDSA Nasdaq
  • WKSP Nasdaq
  • Market Cap
  • EDSA 13.8M
  • WKSP 14.6M
  • IPO Year
  • EDSA N/A
  • WKSP N/A
  • Fundamental
  • Price
  • EDSA $2.08
  • WKSP $3.45
  • Analyst Decision
  • EDSA Strong Buy
  • WKSP Strong Buy
  • Analyst Count
  • EDSA 2
  • WKSP 3
  • Target Price
  • EDSA $13.00
  • WKSP $12.83
  • AVG Volume (30 Days)
  • EDSA 15.0K
  • WKSP 165.1K
  • Earning Date
  • EDSA 08-08-2025
  • WKSP 08-12-2025
  • Dividend Yield
  • EDSA N/A
  • WKSP N/A
  • EPS Growth
  • EDSA N/A
  • WKSP N/A
  • EPS
  • EDSA N/A
  • WKSP N/A
  • Revenue
  • EDSA N/A
  • WKSP $10,211,747.00
  • Revenue This Year
  • EDSA N/A
  • WKSP $159.92
  • Revenue Next Year
  • EDSA N/A
  • WKSP $68.25
  • P/E Ratio
  • EDSA N/A
  • WKSP N/A
  • Revenue Growth
  • EDSA N/A
  • WKSP 407.96
  • 52 Week Low
  • EDSA $1.55
  • WKSP $2.44
  • 52 Week High
  • EDSA $5.59
  • WKSP $12.00
  • Technical
  • Relative Strength Index (RSI)
  • EDSA 55.28
  • WKSP 60.81
  • Support Level
  • EDSA $1.99
  • WKSP $2.73
  • Resistance Level
  • EDSA $2.11
  • WKSP $3.11
  • Average True Range (ATR)
  • EDSA 0.11
  • WKSP 0.27
  • MACD
  • EDSA 0.02
  • WKSP 0.03
  • Stochastic Oscillator
  • EDSA 72.41
  • WKSP 83.72

About EDSA Edesa Biotech Inc.

Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.

About WKSP Worksport Ltd.

Worksport Ltd through its subsidiaries, designs, develops, manufactures, and owns the IP on a variety of tonneau covers, solar integrations, and NP (Non-Parasitic), Hydrogen-based true green energy solutions for the sustainable, clean energy, and automotive industries. The company's product includes soft vinyl tonneau covers and hard aluminum tonneau covers. It operates in two reporting segments for financial reporting purposes: Hard Tonneau Covers and Soft Tonneau Covers. Geographically, the company operates in Canada, United States and Other Countries.

Share on Social Networks: